Acute Anterior Uveitis, Axial Spondyloarthritis research hub

Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis (UP-FOR-U)

This study looks at how a drug called Rinvoq (upadacitinib) affects people with a type of arthritis called axial spondyloarthritis who also experience recurrent eye inflammation (uveitis). It aims to see if Rinvoq can reduce flare-ups of this eye condition.